Japan Diabetes Care Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

Japan Diabetes Care Devices Market Overview

Diabetes care devices incorporate advanced technologies that improve treatment precision, simplify disease monitoring, and encourage proactive patient management. These innovations support enhanced healthcare efficiency. The market is driven by an aging population and increasing diabetes prevalence. The market is poised to grow at a CAGR of 9.70% during the forecast period of 2026-2035, driven by strong technological capabilities and growing demand for high-quality, patient-centered healthcare solutions.

Japan Diabetes Care Devices Market Growth Analysis and Key Influencers

Japan Diabetes Care Devices Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Japan Diabetes Care Devices Market Growth Drivers

Rising Adoption of AI-Powered Digital Diabetes Management Solutions is Accelerating the Market Value

The increasing adoption of artificial intelligence (AI)-enabled smart diabetes management solutions is supporting the expansion of the market by improving continuous glucose monitoring, personalized care, and patient self-management. For instance, in May 2025, Kakao Healthcare established its Japanese subsidiary, KHC Japan, to introduce its AI-powered blood glucose management platform, PASTA, tailored to Japanese users through localized health content, food databases, and AI capabilities. This development reflects the growing demand for advanced digital diabetes care solutions and is expected to strengthen the market.

Japan Diabetes Care Devices Market Restraints

High Cost of Advanced Diabetes Care Devices Limits the Market

The high cost of advanced diabetes care devices, including continuous glucose monitoring systems, insulin pumps, and integrated digital platforms, remains a significant challenge for the market. Although these technologies improve diabetes management and patient outcomes, their affordability can limit adoption among certain patient groups and healthcare providers. In addition, ongoing maintenance, sensor replacement, and software-related expenses further increase the overall cost burden, restricting broader market penetration.

Japan Diabetes Care Devices Market Opportunities

Expansion of Connected Diabetes Management Solutions is Creating New Potential for the Market

The growing focus on connected diabetes management solutions is creating significant potential for the market by improving patient engagement, remote monitoring, and personalized disease management. For example, in March 2023, Astellas Pharma and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution combining the Accu-Chek® Guide Me glucose meter with the AI-enabled BlueStar® digital platform. This collaboration highlights the increasing adoption of connected diabetes technologies, which is expected to support long-term market expansion.

Japan Diabetes Care Devices Market Trends

The market is witnessing several trends, including AI-enabled diabetes management, connected monitoring technologies, and direct commercialization strategies.

Growing Direct Commercialization of Continuous Glucose Monitoring Systems is Strengthening the Market Growth

The increasing shift toward direct commercialization of continuous glucose monitoring (CGM) systems is improving product accessibility, customer support, and innovation within the market. For instance, in October 2023, Dexcom announced its transition to a direct distribution model in Japan, assuming sales and support activities from April 2024. This strategic approach reflects the growing emphasis on direct market engagement and is expected to enhance the long-term development of the market.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

Japan Diabetes Care Devices Market Share

Blood Glucose Monitoring Systems to Dominate the Market by Product Type

Blood glucose monitoring systems are expected to hold a significant share of the market owing to continuous technological advancements in glucose monitoring and increasing demand for painless, convenient diabetes management. For instance, in February 2026, TAMRON invested in Light Touch Technology Inc. to support the commercialization of the world's first needle-free, non-invasive blood glucose sensor. The innovation aims to deliver accurate glucose measurements without blood sampling, highlighting the strong growth potential of advanced blood glucose monitoring systems in the market.

Leading Players in the Japan Diabetes Care Devices Market

Japan Diabetes Care Devices Market Segmentation

Key Questions Answered in the Japan Diabetes Care Devices Market Report

• What was the Japan diabetes care devices market value in 2025?
• What is the Japan diabetes care devices market forecast outlook for 2026-2035?
• What are the major factors aiding the Japan diabetes care devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major diabetes care devices market trends?
• Which product type is expected to dominate the market segment?
• Which disease type is projected to lead the market segment?
• Which patient care setting is anticipated to drive the market segment?
• Who are the key players involved in the Japan diabetes care devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: In-depth interviews conducted with 30+ endocrinologists, diabetologists, diabetes specialty clinic professionals, diabetes care device manufacturers, distributors, procurement managers, and key opinion leaders (KOLs) across Japan, along with selected Asia-Pacific industry experts to assess market trends, technology adoption, and purchasing patterns.
• Secondary Research: Peer-reviewed publications from Diabetes Care, The Lancet Diabetes & Endocrinology, and the Journal of Diabetes Investigation; regulatory publications from the Pharmaceuticals and Medical Devices Agency (PMDA) and Japan's Ministry of Health, Labour and Welfare (MHLW); company annual reports, investor presentations, product portfolios, press releases, and official company websites; and epidemiological data from the International Diabetes Federation (IDF), World Health Organization (WHO), and Japan government health statistics.
• Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling and validated through iterative expert review and feedback.